US expects to approve UK-backed AstraZeneca-Oxford vaccine in April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official says — more than three months after Britain’s green light on Monday.
Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, does not question Britain’s move but tells reporters that US trials will be complete for approval “sometime in early April.”
— AFP
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here







